Dermira, Inc.
275 Middlefield Road
Suite 150
Menlo Park
California
94025
United States
Tel: (650) 421-7200
Fax: 650-365-3410
Website: http://www.dermira.com/
Email: info@dermira.com
112 articles about Dermira, Inc.
-
Dermira Announces Positive Phase 2b Results For DRM04 In Patients With Hyperhidrosis
2/6/2015
-
Dermira To Present At The 2015 Leerink Global Healthcare Conference
1/30/2015
-
Dermira And UCB SA Announce Start Of Phase 3 Program For CIMZIA® (Certolizumab Pegol) In Psoriasis
1/8/2015
-
Dermira Added To Russell 2000® Index
12/22/2014
-
Dermira Reports Third Quarter 2014 Financial Results And Provides Corporate Update
11/13/2014
-
Bay Area's Dermira Supersizes IPO Up 30% To $98M
9/22/2014
-
Redwood City's Dermira Bags $51 Million, Expands Management Team And Board
8/20/2014
-
UCB Group And Dermira Enter Into Strategic Collaboration In Dermatology To Broaden Patient Access To Cimzia® (Certolizumab Pegol)
7/3/2014
-
Dermira Announces Development And Corporate Progress
2/12/2014
-
Company Profile for Dermira
6/13/2013
-
Dermira Raises $35 Million
6/11/2013
-
Dermira Scores $42 Million Series A Financing to Fund Therapeutic Advances in Dermatology
10/21/2011